Quince Therapeutics, Inc.
Quince Therapeutics, Inc. (QNCX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · QNCX · as of Jun 9, 2026
Key Statistics
Explore Quince Therapeutics, Inc. Data
qncx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 22.2%
Competitors & Peers
qncx competitorsQNCX
ADVM
ALXO
ATYR
CAMP
CNTBStock Performance
Full HistoryAbout Quince Therapeutics, Inc.
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive …
what is quince therapeutics, inc. · qncx stock overview · quince therapeutics, inc. company profile · who is quince therapeutics, inc. ceo · qncx NASDAQ · quince therapeutics, inc. headquarters · quince therapeutics, inc. business segments
About Stock Overview & Key Data
Quince Therapeutics, Inc. (QNCX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 9, 2019. As of the latest trading session, QNCX stock price is $1.00, with a market capitalization of $5.6M. The stock has returned -91.45% over the past 12 months and -97.01% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Quince Therapeutics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Quince Therapeutics, Inc. reported revenue of — and net income of -$84.0M. For detailed data — including Quince Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Quince Therapeutics, Inc. (QNCX) stock price is $1.00. The stock is traded on NASDAQ under the ticker symbol QNCX. The 52-week range is $0.79 – $45.50.